 Isradipine treatment hypertension additional effects one-year study placebo run-in phase weeks duration mg mg isradipine year patients hypertensive Good control blood pressure majority patients third month treatment months necessary beta-blocker treatment regimens patients order target blood pressure mm Hg Patients exercise-tested bicycle ergometry months diastolic blood pressure exercise treatment values end placebo run-in baseline values Values systolic blood pressure treatment baseline results decrease peripheral vascular resistance isradipine year results administration beta-blocker bopindolol Sandonorm Sandoz Pharma Basle Switzerland Total cholesterol high-density lipoprotein cholesterol levels treatment Triglycerides months year average value normal range influence isradipine plasma renin activity PRA aldosterone levels values rest exercise PRA first months levels Aldosterone levels months subsequent decrease results diltiazem similar treatment regimen